Healthcare
NDT Pharmaceuticals Inc.(NDTP)
Live Price
Offline$0.50
-5.00% today
1Y Change
+259.71%
Window
Jun 25, 2025 โ Jun 17, 2026
- Market Cap
- $90.00M
- Revenue Growth
- 0.0%
- EPS Growth
- +300.0%
- Dividend Yield
- 0.0%
Coverage: 248 bars ยท Jun 25, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
NDT Pharmaceuticals Inc. (NDTP) is a Healthcare stock with a market cap of $90.00M and listed on OTC. The stock last traded around $0.50 and up 259.7% across the available one-year price window (Jun 25, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +300.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +300.0%, free cash flow 0.0% with operating margin 0.0% and ROIC -49.5%. Stock Foundry combines NDTP price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2008 was reported on Jun 30, 2008, but the surprise data is still limited.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is +300.0%, while operating margin sits near 0.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -48.2% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2008 Jun 30, 2008 | โ | +0.0% | -48.2% | -56.1% |
2008 Mar 30, 2008 | โ | +0.0% | -48.2% | -56.1% |
2007 Dec 31, 2007 | โ | +0.0% | -48.2% | -56.1% |
Benchmark Edge
NDTP vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
NDTP
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
NDTP Max Drawdown
-84.21%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for NDTP and SPY.
Company Overview
NDT Pharmaceuticals Inc.
Other OTC
NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Vienna, Virginia.
- Leadership
- James Hovis
- IPO Date
- Jan 22, 2008
- Street Address
- 8400 Old Courthouse Road
- Mailing
- Vienna, VA, 22182
- Region
- Vienna, VA, US
- Reporting Currency
- USD
- Investor Line
- 402-676-9010
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- โ
- Price/Book
- 1892.5
Growth
- Revenue
- 0.0%
- EPS
- +300.0%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- -33.2%
- ROIC
- -49.5%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.02
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.